Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The FDA’s revision was based on two randomized trials of Viread (tenofovir disoproxil fumarate) use in 2- through 11-year-olds.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
Weight-based Harvoni treatment cured almost almost all of a small group of very young people.
At one hospital in Pittsburgh, the rate of pregnant women with hepatitis C seen for delivery rose 60 percent in eight years.
A roundup of key findings from the Annual Meeting of the American Association for the Study of Liver Diseases in Washington, DC
The surgical practice is common in the United Kingdom but rare in the United States.
A study found that young people treated with biologic drugs for inflammatory bowel disease or various rheumatologic conditions were at risk.
The single-tablet regimen was just approved for adolsecent pediatric use in the United States.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.